IP Library Granted Patent US 10,376,551
Granted Patent B2
US 10,376,551 · App. 15/466,808 · Granted Aug 13, 2019

Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil

Inventors: Ross M Franklin (Rancho Cucamonga, CA); Ed Rosenthal (Oakland, CA); Rachel M. Franklin (Rancho Cucamonga, CA)
Assignee: PIVOT NATURALS, LLC
A61K36/185A21D2/10A21D2/165A21D13/068A21D13/44A21D13/80A23D7/0053A23D9/007A23D9/05A23F3/405A23F5/465A23L2/395A23L2/52A23L2/56A23L7/143A23L27/10A23L29/35A61K9/0056A61K9/0095A61K9/14A61K9/143A61K9/145A61K9/146A61K9/2004A61K9/48A61K31/352A61K36/31A61K38/02A61K47/36A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,376,551
App. No.
15/466,808
Granted
Aug 13, 2019
Kind
B2
Abstract

A method for producing powderized cannabis oil, and the resulting powderized cannabis oil, in which concentrated cannabis oil is mixed with and absorbed by a modified starch powder, preferably maltodextrin, in a ratio of at least three grams of starch powder for every one-eighth of a gram of cannabis oil is disclosed. Further disclosed are beverages, baked goods and single-serve beverage brewing cartridges utilizing or incorporating the powderized cannabis oil to create human-consumable products that contain an emulsified, tasteless, and odorless dose of cannabis oil.

Claims (40)

1. A powderized composition consisting essentially of decarboxylated cannabis oil and maltodextrin.

2. The powderized composition of claim 1 , wherein the decarboxylated cannabis oil has been mixed with the maltodextrin until the cannabis oil is fully absorbed by the maltodextrin.

3. The powderized composition of claim 1 , wherein the ratio of the maltodextrin to the decarboxylated cannabis oil, by weight, is at least three grams of maltodextrin to every one-half of a gram of decarboxylated cannabis oil.

4. The powderized composition of claim 1 , wherein the ratio of the maltodextrin to the decarboxylated cannabis oil, by weight, is at least three grams of maltodextrin to every one-eighth of a gram of decarboxylated cannabis oil.

5. The powderized composition of claim 1 , wherein the ratio of the maltodextrin to the cannabis oil, by weight, is between three grams of maltodextrin for every one-eighth of a gram to one-half of a gram of cannabis oil.

6. The powderized composition of claim 1 , wherein the decarboxylated cannabis oil has been extracted from a cannabis sativa plant.

7. The powderized composition of claim 1 , wherein the decarboxylated cannabis oil has been extracted from a cannabis indica plant.

8. The powderized composition of claim 1 , further consisting essentially of melatonin.

9. The powderized composition of claim 1 , further consisting essentially of diphenhydramine hydrochloride.

10. The powderized composition of claim 1 , further consisting essentially of doxylamine succinate.

11. The powderized composition of claim 1 , further consisting essentially of powdered Valerian root.

12. The powderized composition of claim 1 , further consisting essentially of vitamin B12.

13. The powderized composition of claim 1 , further consisting essentially of caffeine.

14. The powderized composition of claim 1 , further consisting essentially of vitamin C.

15. The powderized composition of claim 1 , further consisting essentially of zinc.

16. The powderized composition of claim 1 , further consisting essentially of iron.

17. The powderized composition of claim 1 , further consisting essentially of calcium.

18. The powderized composition of claim 1 , further consisting essentially of Ginko Biloba.

19. The powderized composition of claim 1 , further consisting essentially of Co-Q 10.

20. The powderized composition of claim 1 , further consisting essentially of magnesium.

21. The powderized composition of claim 1 , further consisting essentially of St. John's Wart.

22. The powderized composition of claim 1 , further consisting essentially of biotin.

23. The powderized composition of claim 1 , further consisting essentially of potassium.

24. The powderized composition of claim 1 , further consisting essentially of fish oil.

25. The powderized composition of claim 1 , further consisting essentially of L-lysine.

26. The powderized composition of claim 1 , further consisting essentially of Ibuprofen.

27. The powderized composition of claim 1 , further consisting essentially of Acetominophen.

28. The powderized composition of claim 1 , further consisting essentially of Naproxen NaCl.

29. The powderized composition of claim 1 , further consisting essentially of aspirin.

30. The powderized composition of claim 1 , further consisting essentially of phenylephrine.

31. The powderized composition of claim 1 , further consisting essentially of chlorpheniramine maleate.

32. The powderized composition of claim 1 , further consisting essentially of Cetirizine HCL.

33. The powderized composition of claim 1 , further consisting essentially of L-lysine.

34. The powderized composition of claim 1 , further consisting essentially of Fexofenadine HCL.

35. The powderized composition of claim 1 , further consisting essentially of Guaifenesin.

36. The powderized composition of claim 1 , further consisting essentially of Dextromethorphan.

37. The powderized composition of claim 1 , further consisting essentially of Famotidine.

38. The powderized composition of claim 1 , further consisting essentially of Omeprazole.

39. The powderized composition of claim 1 , further consisting essentially of Esomeprazole.

40. The powderized composition of claim 1 , further consisting essentially of Lansoprazole.

Assignments (4)
CHANGE OF NAME Recorded Aug 20, 2020
From: PIVOT PHARMACEUTICALS US INC.
To: BETTERLIFE PHARMA US INC.
Reel/Frame 053560/0874 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2019
From: PIVOT NATURALS, LLC
To: PIVOT PHARMACEUTICALS US INC.
Reel/Frame 050997/0641 →
CHANGE OF NAME Recorded Jun 27, 2018
From: ERS HOLDINGS, LLC
To: PIVOT NATURALS, LLC
Reel/Frame 046447/0232 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2018
From: FRANKLIN, ROSS M.; ROSENTHAL, ED; FRANKLIN, RACHEL MELISSA
To: ERS HOLDINGS, LLC
Reel/Frame 045335/0096 →
Continuity (3)
Continuation In Part 15049916 · Feb 22, 2016
Provisional Application 62120275 · Feb 24, 2015
Related Publication 20170189463A1 · Jul 6, 2017
Cited By (1)
US 12,194,018